Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jun;115(4):557–562. doi: 10.1111/j.1476-5381.1995.tb14968.x

Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability.

P Madeddu 1, V Anania 1, M V Varoni 1, P P Parpaglia 1, M P Demontis 1, M C Fattaccio 1, D Palomba 1, D Pollock 1, N Glorioso 1
PMCID: PMC1908501  PMID: 7582472

Abstract

1. We determined whether early inhibition of angiotensin II subtype1 (AT1) receptors by the newly synthesized nonpeptidic antagonist, A-81988, can attenuate the development of hypertension in spontaneously hypertensive rats (SHR) and if the altered blood pressure phenotype can be passed on to the subsequent generation, not exposed to the antagonist. 2. Pairs of SHR were mated while drinking tap water or A-81988 in tap water, and the progeny was maintained on the parental regimen until 14 weeks of age. At this stage, A-81988-treated rats showed lower systolic blood pressure and body weight values (136 +/- 5 versus 185 +/- 4 mmHg and 247 +/- 4 versus 283 +/- 4 g in controls, P < 0.01); while heart rate was similar. In addition, mean blood pressure was reduced (101 +/- 7 versus 170 +/- 7 mmHg in controls, P < 0.01), and the pressor responses to intravenous or intracerebroventricular angiotensin II were inhibited by 27 and 59%, respectively. Heart/body weight ratio was smaller in A-81988-treated rats (3.2 +/- 0.1 versus 3.8 +/- 0.1 in controls, P < 0.01). 3. The antihypertensive and antihypertrophic effect of A-81988 persisted in rats removed from therapy for 7 weeks (systolic blood pressure: 173 +/- 4 versus 220 +/- 4 mmHg, heart/body weight ratio: 3.4 +/- 0.1 versus 4.1 +/- 0.1 in controls at 21 weeks of age, P < 0.01 for both comparisons), whereas the cardiovascular hypertensive phenotype was fully expressed in the subsequent generation that was maintained without treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
557

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker K. M., Aceto J. F. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol. 1990 Aug;259(2 Pt 2):H610–H618. doi: 10.1152/ajpheart.1990.259.2.H610. [DOI] [PubMed] [Google Scholar]
  2. Bao G., Gohlke P., Qadri F., Unger T. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension. 1992 Jul;20(1):74–79. doi: 10.1161/01.hyp.20.1.74. [DOI] [PubMed] [Google Scholar]
  3. Carbone G. M., Sheikh A. U., Rogers S., Brewer G., Rose J. C. Developmental changes in renin gene expression in ovine kidney cortex. Am J Physiol. 1993 Mar;264(3 Pt 2):R591–R596. doi: 10.1152/ajpregu.1993.264.3.R591. [DOI] [PubMed] [Google Scholar]
  4. De B., Winn M., Zydowsky T. M., Kerkman D. J., DeBernardis J. F., Lee J., Buckner S., Warner R., Brune M., Hancock A. Discovery of a novel class of orally active, non-peptide angiotensin II antagonists. J Med Chem. 1992 Oct 2;35(20):3714–3717. doi: 10.1021/jm00098a018. [DOI] [PubMed] [Google Scholar]
  5. DePasquale M. J., Fossa A. A., Holt W. F., Mangiapane M. L. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats. Hypertension. 1992 Jun;19(6 Pt 2):668–671. doi: 10.1161/01.hyp.19.6.668. [DOI] [PubMed] [Google Scholar]
  6. Duncia J. V., Carini D. J., Chiu A. T., Johnson A. L., Price W. A., Wong P. C., Wexler R. R., Timmermans P. B. The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist. Med Res Rev. 1992 Mar;12(2):149–191. doi: 10.1002/med.2610120203. [DOI] [PubMed] [Google Scholar]
  7. Erdös E. G. Angiotensin I converting enzyme. Circ Res. 1975 Feb;36(2):247–255. doi: 10.1161/01.res.36.2.247. [DOI] [PubMed] [Google Scholar]
  8. Fogo A., Yoshida Y., Yared A., Ichikawa I. Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int. 1990 Dec;38(6):1068–1074. doi: 10.1038/ki.1990.314. [DOI] [PubMed] [Google Scholar]
  9. Ganten D., Hermann K., Bayer C., Unger T., Lang R. E. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science. 1983 Aug 26;221(4613):869–871. doi: 10.1126/science.6879184. [DOI] [PubMed] [Google Scholar]
  10. Giudicelli J. F., Freslon J. L., Glasson S., Richer C. Captopril and hypertension development in the SHR. Clin Exp Hypertens. 1980;2(6):1083–1096. doi: 10.3109/10641968009037162. [DOI] [PubMed] [Google Scholar]
  11. Gomez R. A., Lynch K. R., Sturgill B. C., Elwood J. P., Chevalier R. L., Carey R. M., Peach M. J. Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol. 1989 Nov;257(5 Pt 2):F850–F858. doi: 10.1152/ajprenal.1989.257.5.F850. [DOI] [PubMed] [Google Scholar]
  12. Harrap S. B., Van der Merwe W. M., Griffin S. A., Macpherson F., Lever A. F. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990 Dec;16(6):603–614. doi: 10.1161/01.hyp.16.6.603. [DOI] [PubMed] [Google Scholar]
  13. Hermann K., McDonald W., Unger T., Lang R. E., Ganten D. Angiotensin biosynthesis and concentrations in brain of normotensive and hypertensive rats. J Physiol (Paris) 1984;79(6):471–480. [PubMed] [Google Scholar]
  14. Kawano Y., Yoshida K., Matsuoka H., Omae T. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. Am J Hypertens. 1994 Jun;7(6):536–542. doi: 10.1093/ajh/7.6.536. [DOI] [PubMed] [Google Scholar]
  15. Lee J. Y., Warner R. B., Brune M. E., Adler A. L., Winn M., De B., Zydowsky T. M., Opgenorth T. J., Kerkman D. J., DeBernardis J. F. Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats. Am J Hypertens. 1994 Nov;7(11):975–983. doi: 10.1093/ajh/7.11.975. [DOI] [PubMed] [Google Scholar]
  16. Madeddu P., Parpaglia P. P., Demontis M. P., Varoni M. V., Fattaccio M. C., Anania V., Glorioso N. Early blockade of bradykinin B2-receptors alters the adult cardiovascular phenotype in rats. Hypertension. 1995 Mar;25(3):453–459. doi: 10.1161/01.hyp.25.3.453. [DOI] [PubMed] [Google Scholar]
  17. Madeddu P., Parpaglia P. P., Demontis M. P., Varoni M. V., Fattaccio M. C., Glorioso N. Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II. Hypertension. 1994 May;23(5):646–652. doi: 10.1161/01.hyp.23.5.646. [DOI] [PubMed] [Google Scholar]
  18. McDonald W., Wickre C., Aumann S., Ban D., Moffitt B. The sustained antihypertensive effect of chronic cerebroventricular infusion of angiotensin antagonist in spontaneously hypertensive rats. Endocrinology. 1980 Nov;107(5):1305–1308. doi: 10.1210/endo-107-5-1305. [DOI] [PubMed] [Google Scholar]
  19. Nyborg N. C., Mulvany M. J. Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovasc Res. 1985 Sep;19(9):528–536. doi: 10.1093/cvr/19.9.528. [DOI] [PubMed] [Google Scholar]
  20. Okuno T., Nagahama S., Lindheimer M. D., Oparil S. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril. Hypertension. 1983 Sep-Oct;5(5):653–662. doi: 10.1161/01.hyp.5.5.653. [DOI] [PubMed] [Google Scholar]
  21. Pollock D. M., Divish B. J., Polakowski J. S., Opgenorth T. J. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J Pharmacol Exp Ther. 1993 Nov;267(2):657–663. [PubMed] [Google Scholar]
  22. Pollock D. M., Polakowski J. S., Divish B. J., Opgenorth T. J. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension. 1993 May;21(5):660–666. doi: 10.1161/01.hyp.21.5.660. [DOI] [PubMed] [Google Scholar]
  23. Robillard J. E., Weismann D. N., Gomez R. A., Ayres N. A., Lawton W. J., VanOrden D. E. Renal and adrenal responses to converting-enzyme inhibition in fetal and newborn life. Am J Physiol. 1983 Feb;244(2):R249–R256. doi: 10.1152/ajpregu.1983.244.2.R249. [DOI] [PubMed] [Google Scholar]
  24. Saavedra J. M., Correa F. M., Kurihara M., Shigematsu K. Increased number of angiotensin II receptors in the subfornical organ of spontaneously hypertensive rats. J Hypertens Suppl. 1986 Dec;4(5):S27–S30. [PubMed] [Google Scholar]
  25. Sen S., Tarazi R. C., Bumpus F. M. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension. 1980 Mar-Apr;2(2):169–176. doi: 10.1161/01.hyp.2.2.169. [DOI] [PubMed] [Google Scholar]
  26. Timmermans P. B., Chiu A. T., Herblin W. F., Wong P. C., Smith R. D. Angiotensin II receptor subtypes. Am J Hypertens. 1992 Jun;5(6 Pt 1):406–410. doi: 10.1093/ajh/5.6.406. [DOI] [PubMed] [Google Scholar]
  27. Unger T., Kaufmann-Bühler I., Schölkens B., Ganten D. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. Eur J Pharmacol. 1981 Apr 9;70(4):467–478. doi: 10.1016/0014-2999(81)90358-7. [DOI] [PubMed] [Google Scholar]
  28. Unger T., Rettig R. Development of genetic hypertension. Is there a "critical phase"? Hypertension. 1990 Dec;16(6):615–616. doi: 10.1161/01.hyp.16.6.615. [DOI] [PubMed] [Google Scholar]
  29. Wallace K. B., Hook J. B., Bailie M. D. Postnatal development of the renin-angiotensin system in rats. Am J Physiol. 1980 May;238(5):R432–R437. doi: 10.1152/ajpregu.1980.238.5.R432. [DOI] [PubMed] [Google Scholar]
  30. Wu J. N., Berecek K. H. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension. 1993 Aug;22(2):139–146. doi: 10.1161/01.hyp.22.2.139. [DOI] [PubMed] [Google Scholar]
  31. Yang R. H., Jin H., Chen S. J., Wyss J. M., Oparil S. Blocking hypothalamic AT1 receptors lowers blood pressure in salt-sensitive rats. Hypertension. 1992 Dec;20(6):755–762. doi: 10.1161/01.hyp.20.6.755. [DOI] [PubMed] [Google Scholar]
  32. Yosipiv I. V., Dipp S., el-Dahr S. S. Ontogeny of somatic angiotensin-converting enzyme. Hypertension. 1994 Mar;23(3):369–374. doi: 10.1161/01.hyp.23.3.369. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES